Mani Mohindru Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mani Mohindru.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mani Mohindru. Mani Mohindru is Chief Strategy Officer in CURIS INC ($CRIS) and Sr. VP, Corp. Strategy & IR in CURIS INC ($CRIS) and CFO & Chief Strategy Officer in Cara Therapeutics, Inc. ($CARA) and Director in CytomX Therapeutics, Inc. ($CTMX).
Latest Insider Trading Transactions of Mani Mohindru
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CARA, CRIS, CTMX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | CTMX | CytomX Therapeutic ... | Mohindru Mani | Director | Option Exercise | A | 7.45 | 40,000 | 298,000 | 40,000 | |
| Dec 04 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 17.05 | 4,755 | 81,073 | 17,441 | 22.2 K to 17.4 K (-21.42 %) |
| Dec 04 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Grant | A | 0.00 | 8,333 | 0 | 22,196 | 13.9 K to 22.2 K (+60.11 %) |
| Jul 17 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | M | 14.06 | 37,431 | 526,280 | 299,444 | |
| Jul 17 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 25.00 | 37,431 | 935,775 | 13,863 | 51.3 K to 13.9 K (-72.97 %) |
| Jul 17 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Buy | M | 14.06 | 37,431 | 526,280 | 51,294 | 13.9 K to 51.3 K (+270.01 %) |
| May 30 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 21.39 | 2,496 | 53,389 | 13,863 | 16.4 K to 13.9 K (-15.26 %) |
| May 30 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Grant | A | 0.00 | 8,333 | 0 | 16,359 | 8 K to 16.4 K (+103.83 %) |
| Mar 15 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | M | 14.06 | 16,041 | 225,536 | 336,875 | |
| Mar 15 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | M | 14.06 | 16,041 | 225,536 | 336,875 | |
| Mar 15 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 19.12 | 16,041 | 306,704 | 8,026 | 24.1 K to 8 K (-66.65 %) |
| Mar 15 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 19.12 | 16,041 | 306,704 | 8,026 | 24.1 K to 8 K (-66.65 %) |
| Mar 15 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Buy | M | 14.06 | 16,041 | 225,536 | 24,067 | 8 K to 24.1 K (+199.86 %) |
| Mar 15 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Buy | M | 14.06 | 16,041 | 225,536 | 24,067 | 8 K to 24.1 K (+199.86 %) |
| Mar 08 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | A | 16.10 | 75,000 | 1,207,500 | 75,000 | |
| Jan 02 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 12.55 | 4,500 | 56,475 | 8,026 | 12.5 K to 8 K (-35.93 %) |
| Dec 31 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Grant | A | 0.00 | 12,526 | 0 | 12,526 | 0 to 12.5 K |
| Nov 16 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | M | 14.06 | 16,042 | 225,551 | 352,916 | |
| Nov 16 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 18.50 | 16,042 | 296,777 | 0 | 16 K to 0 (-100.00 %) |
| Nov 16 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Buy | M | 14.06 | 16,042 | 225,551 | 16,042 | 0 to 16 K |
| Oct 19 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | M | 14.06 | 16,042 | 225,551 | 368,958 | |
| Oct 19 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 20.19 | 16,042 | 323,888 | 0 | 16 K to 0 (-100.00 %) |
| Oct 19 2018 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Buy | M | 14.06 | 16,042 | 225,551 | 16,042 | 0 to 16 K |
| Aug 24 2017 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | A | 14.06 | 385,000 | 5,413,100 | 385,000 | |
| Feb 16 2017 | CRIS | CURIS INC | Mohindru Mani | Chief Strategy Offi ... | Option Exercise | A | 2.63 | 424,000 | 1,115,120 | 424,000 | |
| Feb 16 2017 | CRIS | CURIS INC | Mohindru Mani | Chief Strategy Offi ... | Option Exercise | A | 2.63 | 424,000 | 1,115,120 | 424,000 | |
| Mar 30 2016 | CRIS | CURIS INC | Mohindru Mani | Chief Strategy Offi ... | Option Exercise | A | 1.51 | 200,000 | 302,000 | 200,000 | |
| Jan 25 2016 | CRIS | CURIS INC | Mohindru Mani | Sr. VP, Corp. Strat ... | Option Exercise | A | 1.76 | 100,000 | 176,000 | 100,000 |
Page: 1